Dave Anttila - Zynex Director HR
| ZYXI Stock | USD 8.32 0.03 0.36% |
Insider
Dave Anttila is Director HR of Zynex Inc
| Address | 9655 Maroon Circle, Englewood, CO, United States, 80112 |
| Phone | 303 703 4906 |
| Web | https://www.zynex.com |
Zynex Management Efficiency
The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1023 %, meaning that it created $0.1023 on every $100 dollars invested by stockholders. Zynex's management efficiency ratios could be used to measure how well Zynex manages its routine affairs as well as how well it operates its assets and liabilities. The Zynex's current Return On Tangible Assets is estimated to increase to 0.09. The Zynex's current Return On Capital Employed is estimated to increase to 0.1. As of now, Zynex's Non Current Assets Total are increasing as compared to previous years. The Zynex's current Non Currrent Assets Other is estimated to increase to about 429.4 K, while Other Assets are projected to decrease to 0.95.Similar Executives
| Showing other executives | INSIDER Age | ||
| N Coles | McKesson | 60 | |
| Kenneth Smith | Owens Minor | 40 | |
| Brad Lerman | McKesson | 63 | |
| Kenny Gardner | Owens Minor | 40 | |
| Ola Snow | Cardinal Health | 56 | |
| Maria Martinez | McKesson | 62 | |
| Kevin Barry | Patterson Companies | 45 | |
| Tammy Gomez | Owens Minor | N/A | |
| Tim Rogan | Patterson Companies | 53 | |
| John Weiland | Cardinal Health | 64 | |
| Stephen Klemash | Owens Minor | 60 | |
| Tom Rodgers | McKesson | 49 | |
| W Dunbar | McKesson | 59 | |
| Shivani Kaul | Patterson Companies | N/A | |
| Aster Angagaw | Owens Minor | 57 | |
| Dave Lardy | Patterson Companies | N/A | |
| Deborah Weitzman | Cardinal Health | 59 | |
| Kevin Emerson | McKesson | 51 | |
| Nicholas II | Owens Minor | 53 | |
| Napoleon Rutledge | McKesson | 52 | |
| Robert Henkel | Owens Minor | 66 | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0399 |
Zynex Inc Leadership Team
Elected by the shareholders, the Zynex's board of directors comprises two types of representatives: Zynex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zynex. The board's role is to monitor Zynex's management team and ensure that shareholders' interests are well served. Zynex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zynex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Sandgaard, Chairman, CEO and President Principal Financial Officer and Principal Accounting Officer | ||
| Anna Lucsok, Chief Officer | ||
| Dave Anttila, Director HR | ||
| Daniel Moorhead, Chief Officer | ||
| Daniel CPA, Chief Officer | ||
| Steve Fox, Executive Sales | ||
| Chelle Burkleo, VP Sales | ||
| Donald Gregg, President Solutions | ||
| Joachim Sandgaard, Information Mang | ||
| Neil Friery, I Solutions |
Zynex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zynex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 302.96 M | ||||
| Shares Outstanding | 31.85 M | ||||
| Shares Owned By Insiders | 51.27 % | ||||
| Shares Owned By Institutions | 28.00 % | ||||
| Number Of Shares Shorted | 4.75 M | ||||
| Price To Earning | 28.60 X |
Currently Active Assets on Macroaxis
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 0.14 | Revenue Per Share 5.984 | Quarterly Revenue Growth 0.001 | Return On Assets 0.0399 |
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.